MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
4.810
+0.250 (5.48%)
At close: May 12, 2025, 4:00 PM
4.717
-0.093 (-1.93%)
After-hours: May 12, 2025, 6:43 PM EDT
MannKind Revenue
MannKind had revenue of $78.35M in the quarter ending March 31, 2025, with 18.25% growth. This brings the company's revenue in the last twelve months to $297.60M, up 32.50% year-over-year. In the year 2024, MannKind had annual revenue of $285.50M with 43.50% growth.
Revenue (ttm)
$297.60M
Revenue Growth
+32.50%
P/S Ratio
4.57
Revenue / Employee
$731,192
Employees
407
Market Cap
1.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 285.50M | 86.54M | 43.50% |
Dec 31, 2023 | 198.96M | 99.19M | 99.42% |
Dec 31, 2022 | 99.77M | 24.33M | 32.25% |
Dec 31, 2021 | 75.44M | 10.30M | 15.81% |
Dec 31, 2020 | 65.14M | 2.11M | 3.34% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MNKD News
- 4 days ago - MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025 - GlobeNewsWire
- 5 weeks ago - MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options - GlobeNewsWire
- 2 months ago - MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22 - GlobeNewsWire
- 2 months ago - MannKind Q4 Review: Solid Financials, But Tyvaso DPI's Market Share In Question - Seeking Alpha
- 2 months ago - MannKind Corporation (MNKD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire